SYVA COMPANY – Trademark Portfolio
Entity Type: 03
SYVA COMPANY owns a portfolio of 39 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EMIT, SYVA, VISTA, and D.A.U.. Of these, 8 are registered. The portfolio spans 5 Nice Classification classes, led by Class 1 (Chemicals) and Class 9 (Computers & Electronics). Headquartered in SAN JOSE, CA.
3403 YERBA BUENA ROAD
SAN JOSE, CA 95135
Showing of trademarks Trademarks
Trademark Classifications
SYVA COMPANY's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does SYVA COMPANY have?
SYVA COMPANY has 39 U.S. trademarks filed with the USPTO. Of these, 8 registered, 2 abandoned, 29 cancelled.
What trademark classes does SYVA COMPANY file in?
SYVA COMPANY files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are SYVA COMPANY's most well-known trademarks?
SYVA COMPANY's registered trademark portfolio includes well-known marks such as EMIT, SYVA, VISTA, and D.A.U.. These are among 8 currently registered trademarks in the portfolio.
What is SYVA COMPANY's trademark registration success rate?
SYVA COMPANY has a 21% trademark registration rate, with 8 out of 39 resolved applications resulting in successful registration. Currently, 0 applications are pending review.